Mallia

Mallia is a dynamic biotechnology research company focused on developing innovative cosmetic and biopharmaceutical solutions, particularly in the realm of hair growth and hair loss therapies. Mallia is committed to leveraging cutting-edge science to create effective products that address significant dermatological needs.

Strategically structured, Mallia Innovations GmbH acts as the holding company, guiding the development and commercialization of both cosmetic applications and biopharmaceutical therapies centered around the immune modulatory sCD83 protein. This protein is targeted for its potential in stimulating hair growth, combating hair loss, and aiding in wound healing. The company operates with a clear vision, driving advancements in dermatological treatments. Mallia is located at Henkestrasse 91, Erlangen, 91052, DE.

With a focus on innovation and patient well-being, Mallia is dedicated to expanding its portfolio and making a meaningful impact on the biotechnology landscape. The information regarding Mallia’s latest achievements and upcoming projects will be completed soon with the support of the company’s management. We invite the manager of Mallia to create a customized and exclusive company showcase and product listing on our platform to further highlight their groundbreaking work.